Tysabri Lawsuits
Tysabri is a medication that was developed to keep the physical limitations of multiple sclerosis at bay and as a last ditch effort for those suffering from the disease who did not have improvements with other drugs. Tysabri is manufactured by Biogen Idec, Inc. and was approved by the Food and Drug Administration in 2006 as a monotherapy (not to be combined with any other drug therapies) in the treatment of MS. It has also been used to treat Crohn's Disease.
Tysabri has been shown to increase the risk of progressive multifocal leukoencephalopathy or PML, a viral infection of the brain that could lead to death. The symptoms of PML include progressive weakness usually just on one side of the body, vision problems, disorientation and confusion. These changes can come about after just a few days or weeks of using Tysabri. Because this drug has such a drastic side effect it was only prescribed to MS patients who didn't respond to any other medications of this type.
The drug is administered by IV once every four weeks and because of its risk factor is only available through the TOUCH Prescribing program. The FDA started this medication out with one of its most serious warnings, the black box label, warning users of the risk of PML.
Based on information coming in about the side effects of Tysabri the FDA added an additional warning in February 2008. The drug was shown to increase your chances of experiencing liver damage after only one dose. Signs of liver problems include jaundice of the skin and eyes, dark urine, nausea, feelings of being tired and weak, and vomiting. If you are experiencing any of these signs your doctor can do a blood test to see if it is liver damage.
Tysabri was pulled from the market in 2005 because of the increased reports of PML. The company made changes to Tysabri and re-introduced it back onto the market in 2006. As of June 2009 Biogen confirmed the 10th case of PML by a patients who used their drug Tysabri.
If you, someone in your family or anyone you know has multiple sclerosis and has gotten PML as a result of using Tysabri please contact us here at Napoli Bern Ripka Law Firm. You may be eligible for compensation through any number of class action suits against the makers of this drug.
If you live in New York you can make an appointment to come to our office which is located in the Empire State building. We also have offices throughout the country. We are committed to helping our clients realize the justice that they deserve.
Please take a minute and fill out our Quick Contact form on our home page or give us a call at 1-888-LAW-IN-NY (888-529-4669). We have recovered over a billion dollars for our clients. Let us put our expertise to work for you.
Cases and Settlements of Note
FDA Lawsuits & Settlements
- Diet Drug (Phentermine, fenfluramine, dexfenfluramine) Products Liability Litigation. The firm achieved a landmark settlement of half-a-billion dollars on behalf of thousands of plaintiffs injured as a result of their ingestion of defective diet medications.
- Client v. Bayer Corporation. The firm achieved settlements totaling over $1M on behalf of plaintiffs injured as a result of being administered the defective drug Trasylol during heart surgery.
Attorney Advertising: Prior results do not guarantee a similar outcome. This website is for informational purposes only, does not constitute legal advice and may not reflect the most current legal developments. Use of this website does not create an attorney-client relationship, only a written contract between the parties can establish an attorney-client relationship. Napoli Bern Ripka Shkolnik LLP and all contributing authors expressly disclaim all liability to any person with respect to the contents of this website. Imagery used on this website utilizes fictionalized events or scenes with participation of models. For complete details, read our Terms of Use and Privacy Policy.
(888) 529 4669
